Thursday, January 26, 2006

MONITORING GRAVE'S DISEASE WITH TSI

Ophthalmic Plastic & Reconstructive Surgery. 22(1):13-19, January/February 2006

This study was undertaken to evaluate the potential usefulness of measured thyroid-stimulating immunoglobulin (TSI) values in following and treating patients with Grave's Disease.

It was found that changes in eye signs of Grave's Disease statistically correlate with changes in measured TSI.

The study concludes:
"These findings suggest that serial TSI measurements may be an adjunct in assessing clinical inflammatory activity of Thyroid-Associated Orbitopathy and may help direct clinical decision making regarding treatment decisions."

No comments:

Post a Comment

Leave a Comment or Question: